Omega-3 fatty acid ethyl esters

DRUG2 trials

Sponsors

Takeda

Conditions

Hyperlipidemia

Unknown Phase

Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters

CompletedNCT02153073

TakedaHyperlipidemia

Start: 2013-05-29End: 2017-05-31Updated: 2019-07-18

Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3

CompletedNCT02285166

TakedaHyperlipidemia

Start: 2014-10-21End: 2020-07-14Updated: 2022-02-18

Related Papers

Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey)

Expert Opinion on Drug Safety2022-06-301 citations